2026 ASCO Annual Meeting: BofA's Jason Gerberry on what to expect

Jason Gerberry, BofA Securities senior large-cap pharma analyst, joins 'Squawk Box' to discuss the 2026 ASCO Annual Meeting, what to expect from the conference, latest cancer treatment announcements, and more.